Literature DB >> 9355897

Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia.

M S Lüscher1, K Thygesen, J Ravkilde, L Heickendorff.   

Abstract

BACKGROUND: Studies have demonstrated that troponin T is a strong independent indicator of a poor prognosis in patients with unstable coronary artery disease. Up to the present, no study has compared the prognostic value of troponin T with that of troponin I in the same cohort of patients. METHODS AND
RESULTS: Patients (n=516) suspected of having unstable coronary artery disease were investigated. Follow-up was done after 30 days, and the occurrences of cardiac death, acute myocardial infarction, refractory angina pectoris, and recurrent angina pectoris were registered. Elevated levels of troponin T (> or = 0.10 microg/L) were associated with an increased risk of cardiac death at 30 days compared with patients with normal levels, 3.2% versus 0.4% (P=.014). Troponin I values above the chosen cutoff (2.0 microg/L) were similarly found to be an indicator of increased risk of cardiac death, 3.2% versus 0.7% (P=.026). With regard to the composite end point of cardiac death/acute myocardial infarction, the troponins were strong independent indicators of adverse outcome.
CONCLUSIONS: In patients suspected of having unstable coronary artery disease, both troponin T and troponin I provide independent prognostic information with regard to cardiac death and acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355897     DOI: 10.1161/01.cir.96.8.2578

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

Review 1.  Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit.

Authors: 
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

2.  Acute coronary syndromes: risk stratification.

Authors:  A Timmis
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 3.  Management of acute coronary syndromes.

Authors:  S J Maynard; G O Scott; J W Riddell; A A Adgey
Journal:  BMJ       Date:  2000-07-22

4.  Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers.

Authors:  S Kennon; C P Price; P G Mills; P K MacCallum; J Cooper; J Hooper; H Clarke; A D Timmis
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 5.  Critical review of unstable angina and non-ST elevation myocardial infarction.

Authors:  P J Sheridan; D C Crossman
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

Review 6.  Perspective on the clinical application of troponin in heart failure and states of cardiac injury.

Authors:  Almasa Bass; J Herbert Patterson; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2009-04-05       Impact factor: 4.214

7.  Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.

Authors:  T Nageh; R A Sherwood; B M Harris; M R Thomas
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

8.  Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.

Authors:  Thao Huynh; James Nasmith; The Minh Luong; Martin Bernier; Chantal Pharand; Zhao Xue-Qiao; Robert P Giugliano; Pierre Theroux
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

9.  ROMEO: a rapid rule out strategy for low risk chest pain. Does it work in a UK emergency department?

Authors:  C Taylor; A Forrest-Hay; S Meek
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

10.  Troponin elevation in subarachnoid hemorrhage does not impact in-hospital mortality.

Authors:  Manisha Gupte; Sayona John; Shyam Prabhakaran; Vivien H Lee
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.